Antimalarial-agent artemisinin and derivatives portray more potent binding to Lys353 and Lys31-binding hotspots of SARS-CoV-2 spike protein than hydroxychloroquine: potential repurposing of artenimol for COVID-19
Moussa Sehailia, Smaïn Chemat
Abstract
L. is proposed in order to cope with the potential urgent global demand. Communicated by Ramaswamy H. Sarma.
Topics & Concepts
HydroxychloroquineRepurposingSpike ProteinCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Drug repositioning2019-20 coronavirus outbreakArtemisininVirologyBiologyPlasmodium falciparumPharmacologyMalariaMedicineInfectious disease (medical specialty)DrugEcologyPathologyImmunologyDiseaseOutbreakComputational Drug Discovery MethodsMalaria Research and ControlSARS-CoV-2 and COVID-19 Research